Diagnosing Polymyalgia Rheumatica
Polymyalgia rheumatica (PMR) is diagnosed clinically in patients over 50 years old presenting with bilateral shoulder and/or hip girdle pain, morning stiffness lasting >30-60 minutes, and elevated inflammatory markers (ESR/CRP), after systematically excluding septic arthritis, malignancy, and giant cell arteritis. 1, 2
Clinical Diagnostic Criteria
The diagnosis is primarily clinical and requires:
- Age >50 years - this is an absolute requirement 2, 3
- Bilateral shoulder pain with or without pelvic girdle involvement, developing over weeks 2, 4
- Morning stiffness lasting >30-60 minutes to 1 hour, improving with activity 5, 3
- Elevated inflammatory markers (ESR and CRP) in >90% of cases, though a small proportion may have normal values 2, 4
- Dramatic response to glucocorticoids within 24-48 hours - failure to respond should prompt reconsideration of the diagnosis 6, 7
Essential Diagnostic Workup
Initial laboratory evaluation must include:
- ESR and CRP - elevated in >90% of cases 2, 3
- Creatine kinase (CK) - must be normal to differentiate from myositis 5
- Rheumatoid factor (RF) and anti-CCP - should be negative 5
- Complete blood count - may show anemia of chronic disease 2
- Thyroid function tests - to exclude thyroid disease as a mimic 4
Imaging studies to support diagnosis:
- Ultrasound of shoulders - bilateral subdeltoid bursitis is present in 69% of PMR patients and significantly improves diagnostic accuracy 2, 7
- X-rays of affected joints - to exclude other pathology when diagnosis is uncertain 5
- MRI - may show mild shoulder joint effusion and bursitis 5
Critical Differential Diagnoses to Exclude First
You must systematically rule out these high-priority conditions:
Giant cell arteritis (GCA) - present in up to 20% of PMR patients 4
Septic arthritis - requires urgent arthrocentesis if suspected 1
Malignancy - PMR may be the first manifestation of cancer 7, 4
- Age-appropriate cancer screening is mandatory 4
Rheumatoid arthritis - look for small joint involvement, positive RF/anti-CCP, and symmetric polyarthritis 7, 4
Myositis - distinguished by true muscle weakness (not just pain), elevated CK, and abnormal EMG 5
Infection - consider in patients with fever and failure to respond to glucocorticoids 7
Common Diagnostic Pitfalls
Avoid these errors:
- Overdiagnosis - many conditions mimic PMR including bilateral shoulder capsulitis, osteoarthritis, Parkinsonism, and depression 4
- Missing GCA - failure to ask about headache, jaw claudication, and visual symptoms at every visit can lead to preventable blindness 4
- Assuming normal inflammatory markers exclude PMR - a small proportion of patients have normal ESR/CRP 4
- Not checking CK levels - this is essential to differentiate PMR from myositis, which can be life-threatening if myocarditis is present 5
Treatment Approach
Initial glucocorticoid therapy:
- Prednisone 12.5-25 mg daily is the standard starting dose for PMR 2
- Expect dramatic improvement within 24-48 hours - lack of response should prompt diagnostic reconsideration 6, 7
- Taper slowly over months to minimize relapse risk 2, 7
Adjunctive therapy:
- Methotrexate reduces cumulative glucocorticoid dose by 20-44% and relapses by 36-54% in patients requiring prolonged therapy or at risk for glucocorticoid-related adverse effects 2, 8
- Tocilizumab or secukinumab are promising alternatives for refractory cases 8
Monitoring Strategy
Serial assessments every 4-6 weeks should include:
- ESR and CRP to monitor disease activity 1
- Screening for GCA symptoms at every visit 4
- Assessment of glucocorticoid side effects including bone density, glucose, blood pressure 8
- Functional assessment particularly upper extremity function and activities of daily living 8
Refer to rheumatology if: